Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Viking Therapeutics (VKTX) stock

Learn how to easily invest in Viking Therapeutics stock.

Viking Therapeutics, Inc
NASDAQ: VKTX - USD
BIOTECHNOLOGY
$5.69
+$0.06 (+1.07%)

Viking Therapeutics, Inc is a biotechnology business based in the US. Viking Therapeutics shares (VKTX) are listed on the NASDAQ and all prices are listed in US Dollars. Viking Therapeutics employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Viking Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VKTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Viking Therapeutics stock price (NASDAQ: VKTX)

Use our graph to track the performance of VKTX stocks over time.

Viking Therapeutics shares at a glance

Information last updated 2021-07-22.
Latest market close$5.26
52-week range$5.12 - $10.09
50-day moving average $6.00
200-day moving average $6.43
Wall St. target price$18.92
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.35

Buy Viking Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Viking Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Viking Therapeutics price performance over time

Historical closes compared with the close of $5.26 from 2021-06-04

1 week (2021-07-17) N/A
1 month (2021-06-28) -17.94%
3 months (2021-04-28) -17.30%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Viking Therapeutics financials

Gross profit TTM $0
Return on assets TTM -10.89%
Return on equity TTM -17.34%
Profit margin 0%
Book value $3.07
Market capitalisation $458.4 million

TTM: trailing 12 months

Shorting Viking Therapeutics shares

There are currently 8.1 million Viking Therapeutics shares held short by investors – that's known as Viking Therapeutics's "short interest". This figure is 17.8% down from 9.9 million last month.

There are a few different ways that this level of interest in shorting Viking Therapeutics shares can be evaluated.

Viking Therapeutics's "short interest ratio" (SIR)

Viking Therapeutics's "short interest ratio" (SIR) is the quantity of Viking Therapeutics shares currently shorted divided by the average quantity of Viking Therapeutics shares traded daily (recently around 1.2 million). Viking Therapeutics's SIR currently stands at 6.95. In other words for every 100,000 Viking Therapeutics shares traded daily on the market, roughly 6950 shares are currently held short.

However Viking Therapeutics's short interest can also be evaluated against the total number of Viking Therapeutics shares, or, against the total number of tradable Viking Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Viking Therapeutics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Viking Therapeutics shares in existence, roughly 100 shares are currently held short) or 0.1326% of the tradable shares (for every 100,000 tradable Viking Therapeutics shares, roughly 133 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Viking Therapeutics.

Find out more about how you can short Viking Therapeutics stock.

Viking Therapeutics share dividends

We're not expecting Viking Therapeutics to pay a dividend over the next 12 months.

Viking Therapeutics share price volatility

Over the last 12 months, Viking Therapeutics's shares have ranged in value from as little as $5.12 up to $10.09. A popular way to gauge a stock's volatility is its "beta".

VKTX.US volatility(beta: 1.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viking Therapeutics's is 1.8373. This would suggest that Viking Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Viking Therapeutics overview

Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. .

Stocks similar to Viking Therapeutics

Frequently asked questions

What percentage of Viking Therapeutics is owned by insiders or institutions?
Currently 10.115% of Viking Therapeutics shares are held by insiders and 53.974% by institutions.
How many people work for Viking Therapeutics?
Latest data suggests 18 work at Viking Therapeutics.
When does the fiscal year end for Viking Therapeutics?
Viking Therapeutics's fiscal year ends in December.
Where is Viking Therapeutics based?
Viking Therapeutics's address is: 12340 El Camino Real, San Diego, CA, United States, 92130
What is Viking Therapeutics's ISIN number?
Viking Therapeutics's international securities identification number is: US92686J1060
What is Viking Therapeutics's CUSIP number?
Viking Therapeutics's Committee on Uniform Securities Identification Procedures number is: 92686J106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site